Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 30;21:1165. doi: 10.1186/s12885-021-08827-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

PMC Copyright notice

Fig. 2 — Correlation analysis of the 25-lncRNA risk signature with HCC early recurrence in the training cohort. A) The 150 HCC patients in the training cohort was ranked according to their risk scores from low to high, and the median risk score was set as the cut-off to divide the 150 HCC patients into low-risk group (n = 75) and high-risk group (n = 75); B) The 25-lncRNA expression profile in the 150 HCC patients. The 19 risk lncRNAs were enriched in the high-risk group and the 6 protective lncRNAs were enriched in the low-risk group; C) 81.25% and 76.06% HCC patients with recurrence in 1-year and 2-year respectively were classified in the high-risk group, and 18.72% and 23.94% HCC patients with recurrence in 1-year and 2-year respectively were classified in the low-risk group (P = 0.005)